MarketPeel
Insider Trading Intelligence
Pricing
…
QP

Quang X. Pham

CVKD
CEO AND CHAIRMAN · CADRENAL THERAPEUTICS, INC. · CIK 0001405290
FILING MIX · LIFETIME24%/76%
BUYS
11
SELLS
35
TOTAL VALUE
$849.3K
COMPANIES
1
ACTIVE SINCE
Feb 2023
HOLDINGS NOW
98,589
AVG SELL PX
$5.85
TRADE KIND
SHOWING 46 / 46
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
18 backtested trades · 8 horizons · 22 pending
Forward-return performance of every backtestable P/S trade by Quang X. Pham, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d18+66.67%-0.26%-0.17%-0.09%-0.69%—
14d18+38.89%-6.38%-0.17%-6.22%-8.83%—
30d18+44.44%-13.42%-0.94%-12.47%-15.86%—
60d18+61.11%-36.87%-0.72%-36.15%-40.87%—
90d18+61.11%-44.89%+2.69%-47.58%-49.88%—
180d18+61.11%-45.87%+5.67%-51.55%-55.93%—
1y18(11 pending)+0.00%-41.55%+26.02%-67.56%-69.70%—
2y18(11 pending)+0.00%-3.35%+46.78%-50.13%-49.37%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
CVKD · 98,589 shares · as of Jun 29, 2026
0852,5001,705,0002,557,5003,410,000202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 11 buys / 35 sellsCOVERAGE · 14 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CVKD
CADRENAL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
7,400$3.03$22.4K98,589Jun 29, 2026Jul 1, 2026 ↗View →
CVKD
CADRENAL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
9,029$3.05$27.5K105,989Jun 26, 2026Jun 26, 2026 ↗View →
CVKD
CADRENAL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,127$3.00$6.4K115,018Jun 25, 2026Jun 26, 2026 ↗View →
CVKD
CADRENAL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,277$3.20$7.3K117,145Jun 23, 2026Jun 24, 2026 ↗View →
CVKD
CADRENAL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
9,167$3.55$32.5K119,422Jun 22, 2026Jun 24, 2026 ↗View →
CVKD
CADRENAL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
513$3.16$1.6K128,589Jun 17, 2026Jun 18, 2026 ↗View →
CVKD
CADRENAL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
3,613$3.18$11.5K129,102Jun 16, 2026Jun 18, 2026 ↗View →
CVKD
CADRENAL THERAPEUTICS, INC.
SALE
Chairman, CEO and Interim CFO
3,666$3.58$13.1K132,715Jun 15, 2026Jun 15, 2026 ↗View →
CVKD
CADRENAL THERAPEUTICS, INC.
SALE
Chairman, CEO and Interim CFO
12,996$3.94$51.2K136,381Jun 12, 2026Jun 15, 2026 ↗View →
CVKD
CADRENAL THERAPEUTICS, INC.
SALE
Chairman, CEO and Interim CFO
1,462$4.12$6.0K149,377Jun 11, 2026Jun 15, 2026 ↗View →
CVKD
CADRENAL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
3,500$4.21$14.7K150,839Jun 10, 2026Jun 10, 2026 ↗View →
CVKD
CADRENAL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
12,992$4.06$52.7K154,339Jun 9, 2026Jun 10, 2026 ↗View →
CVKD
CADRENAL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
5,893$4.38$25.8K167,331Jun 8, 2026Jun 10, 2026 ↗View →
CVKD
CADRENAL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,064$4.42$9.1K173,224Jun 5, 2026Jun 5, 2026 ↗View →
CVKD
CADRENAL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
3,898$4.41$17.2K175,288Jun 4, 2026Jun 5, 2026 ↗View →
CVKD
CADRENAL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,323$4.26$9.9K179,186Jun 3, 2026Jun 5, 2026 ↗View →
CVKD
CADRENAL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
349$4.46$1.6K181,509Jun 2, 2026Jun 2, 2026 ↗View →
CVKD
CADRENAL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
303$5.01$1.5K181,858May 29, 2026Jun 2, 2026 ↗View →
CVKD
CADRENAL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,989$4.93$14.7K182,161May 28, 2026May 29, 2026 ↗View →
CVKD
CADRENAL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,165$5.69$6.6K194,924May 22, 2026May 26, 2026 ↗View →
CVKD
CADRENAL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
3,298$5.28$17.4K185,150May 12, 2026May 29, 2026 ↗View →
CVKD
CADRENAL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
6,476$5.76$37.3K188,448May 11, 2026May 29, 2026 ↗View →
CVKD
CADRENAL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,315$13.99$18.4K196,089Oct 27, 2025Oct 28, 2025 ↗View →
CVKD
CADRENAL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,129$14.03$15.8K197,404Oct 24, 2025Oct 28, 2025 ↗View →
CVKD
CADRENAL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,800$14.15$25.5K198,533Oct 13, 2025Oct 14, 2025 ↗View →
CVKD
CADRENAL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,800$14.02$25.2K200,333Oct 9, 2025Oct 14, 2025 ↗View →
CVKD
CADRENAL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
500$14.13$7.1K202,133Oct 2, 2025Oct 3, 2025 ↗View →
CVKD
CADRENAL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
881$14.01$12.3K202,633Oct 1, 2025Oct 1, 2025 ↗View →
CVKD
CADRENAL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
419$14.01$5.9K203,514Sep 29, 2025Oct 1, 2025 ↗View →
CVKD
CADRENAL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
6,790$14.09$95.7K203,933Sep 25, 2025Sep 26, 2025 ↗View →
CVKD
CADRENAL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,581$13.99$36.1K210,723Sep 24, 2025Sep 26, 2025 ↗View →
CVKD
CADRENAL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,193$13.99$16.7K213,304Aug 28, 2025Aug 29, 2025 ↗View →
CVKD
CADRENAL THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
3,836$13.99$53.7K214,497Aug 27, 2025Aug 29, 2025 ↗View →
CVKD
CADRENAL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
65,000——65,000Jan 23, 2025Jan 24, 2025 ↗View →
CVKD
CADRENAL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
65,000——65,000Jan 23, 2025Mar 24, 2025 ↗View →
CVKD
CADRENAL THERAPEUTICS, INC.
SALEGRANT
Gift
50,000——3,275,000Apr 10, 2024Apr 10, 2024 ↗View →
CVKD
CADRENAL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
150,000——150,000Jan 18, 2024Jan 19, 2024 ↗View →
CVKD
CADRENAL THERAPEUTICS, INC.
SALEGRANT
Gift
85,000——3,325,000Oct 23, 2023Feb 12, 2024 ↗View →
CVKD
CADRENAL THERAPEUTICS, INC.
PURCHASE
CEO and Chairman
20,000$0.91$18.2K3,390,000Sep 5, 2023Sep 6, 2023 ↗View →
CVKD
CADRENAL THERAPEUTICS, INC.
PURCHASE
CEO and Chairman
20,000$0.90$18.0K3,410,000Sep 5, 2023Sep 6, 2023 ↗View →
CVKD
CADRENAL THERAPEUTICS, INC.
PURCHASE
CEO and Chairman
20,000$0.92$18.4K3,350,000Sep 1, 2023Sep 5, 2023 ↗View →
CVKD
CADRENAL THERAPEUTICS, INC.
PURCHASE
CEO and Chairman
10,000$0.84$8.4K3,370,000Sep 1, 2023Sep 5, 2023 ↗View →
CVKD
CADRENAL THERAPEUTICS, INC.
PURCHASE
CEO and Chairman
10,000$0.92$9.2K3,360,000Sep 1, 2023Sep 5, 2023 ↗View →
CVKD
CADRENAL THERAPEUTICS, INC.
PURCHASE
CEO and Chairman
10,000$0.93$9.3K3,310,000Sep 1, 2023Sep 5, 2023 ↗View →
CVKD
CADRENAL THERAPEUTICS, INC.
PURCHASE
CEO and Chairman
20,000$0.93$18.6K3,330,000Sep 1, 2023Sep 5, 2023 ↗View →
CVKD
CADRENAL THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
25,000$1.94$48.5K3,300,000Feb 10, 2023Feb 13, 2023 ↗View →
Other insiders · CVKD
Loading peer insiders…
About this filer
CIK 0001405290
ROLE
CEO and Chairman
PRIMARY
CVKD
COMPANIES
1
ACTIVE SINCE
Feb 2023
MARKETPEEL · /INSIDER/0001405290DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback